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ABSTRACT 46 
Background: Twin studies have revealed a significant contribution of the fetal genome to risk of 47 
preterm birth.  Preterm premature rupture of membranes (PPROM) is the leading identifiable 48 
cause of preterm delivery. Infection and inflammation of the fetal membranes is commonly 49 
found associated with PPROM.     50 
Methods: We carried out whole exome sequencing (WES) of genomic DNA from neonates born 51 
of African-American mothers whose pregnancies were complicated by PPROM (76) or were 52 
normal term pregnancies (N=43) to identify mutations in 35 candidate genes involved in innate 53 
immunity and host defenses against microbes.   Targeted genotyping of mutations in the 54 
candidates discovered by WES was conducted on an additional 188 PPROM cases and 175 55 
controls.   56 
Results: We identified rare heterozygous nonsense and frameshift mutations in several of the 57 
candidate  genes, including CARD6, CARD8, DEFB1, FUT2, MBL2, NLP10, NLRP12, and 58 
NOD2. We discovered that some mutations (CARD6, DEFB1, FUT2, MBL2, NLRP10, NOD2) 59 
were present only in PPROM cases.   60 
Conclusions: We conclude that rare damaging mutations in innate immunity and host defense 61 
genes, the majority being heterozygous, are more frequent in neonates born of pregnancies 62 
complicated by PPROM.  These findings suggest that the risk of preterm birth in African-63 
Americans may be conferred by mutations in multiple genes encoding proteins involved in 64 
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dampening the innate immune response or protecting the host against microbial infection and 65 
microbial products. 66 
Key Words: Preterm birth, preterm premature rupture of membranes, innate immunity, anti-67 
microbial peptides, inflammasome, mannose-binding lectin protein, fucosyltransferase, 68 
defensins, chorioamnionitis 69 
 70 
 71 
INTRODUCTION 72 
Preterm birth, especially among African-Americans, has challenged the U.S. health care 73 
system for decades (Behrman & Butler, 2007; Kempe et al., 1992; Aveyard et al., 2002; Ahern 74 
et al., 2003; Shen et al., 2003). The disparities in prematurity among U.S. populations is thought 75 
to be the result of multiple biological and environmental factors (Meis et al., 2000; Anum et al., 76 
2009b; Moutquin, 2003).  Preterm premature rupture of membranes (PPROM) is the leading 77 
identifiable cause of preterm birth, and more common among African-Americans.  Our research 78 
has been focused on understanding the pathophysiology of PPROM, and the factors that 79 
contribute to population-specific risk (Parry and Strauss, 1998; Strauss, 2013). 80 
The notion that heritable factors play an important role in preterm birth is supported by 81 
studies based on twins (Boyd et al., 2009; Svensson et al., 2009; York et al., 2009; York et al. 82 
2010, 2013, 2014, 2015). These studies demonstrated that both the fetal and maternal 83 
genomes contribute to the timing of parturition. In addition, there is increasing evidence that 84 
gene-environment interactions amplify the effect of specific alleles (Anum et al., 2009b; Wang et 85 
al., 2002; Macones et al., 2004).  However, the search for maternal and fetal genes linked to 86 
preterm birth has yet to produce robust and reproducible candidates.  Although association 87 
studies have found significant relationships for some candidate genes, the primary reports and 88 
available meta-analyses indicate that these associations are weak or population specific (e.g., 89 
Genc et al., 2002; Fujimoto et al., 2002; Ferrand et al., 2002b; Lorenz et al., 2002;  Moore et al., 90 
2004; Roberts et al., 1999; Romero et al., 2010; Simhan et al., 2003; Witkin et al., 2003; Wang 91 
et al., 2004; 2006; 2008;  see Sheikh et al., 2016 for a recent review).  Moreover, attempts to 92 
identify loci contributing to prematurity through genome-wide association studies (GWAS) have 93 
not delivered strong candidates (Parets et al., 2015), prompting investigators to pursue 94 
alternative approaches to identify genes contributing to preterm birth (Brubaker et al., 2016; 95 
Bacelis et al., 2016).  Recently, we took a different approach based on the hypothesis that rare 96 
mutations or damaging variants in multiple genes (which might escape detection by GWAS or 97 
standard association studies, especially with small sample sizes) make significant contributions 98 
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to PPROM (Modi et al., 2017). The approach was based on mutation/damaging variant 99 
detection using whole exome sequencing (WES), which we applied in this study to explore fetal 100 
gene mutations in the innate immune system and  PPROM.  101 
Innate immunity encompasses recognition systems that detect molecules derived from 102 
bacteria and viruses (Pathogen-Associated Molecular Patterns (PAMPs)) and endogenous 103 
alarmins (Damaged-Associated Molecular Patterns (DAMPs)). Pattern recognition receptors 104 
(PRRs) responsible for the initiation of innate immune response induced by PAMPs and DAMPs 105 
include NOD-like receptor family pyrin domain containing proteins and toll-like receptors (TLR). 106 
The response triggered by the PRRs includes activation of transcription of genes that encode 107 
cytokines and factors that resolve infection/inflammation (Brubaker et al., 2015). Enhanced 108 
production of pro-inflammatory cytokines has been postulated to play a central role in preterm 109 
birth and PPROM (Parry & Strauss, 1998; Murtha & Menon, 2015;Gomez-Lopez et al., 2017).  110 
The pro-inflammatory cytokines induce expression of matrix metalloproteinases which degrade 111 
fetal membrane extracellular matrix leading to rupture (Parry and Strauss, 1998; Strauss, 2013).  112 
The innate immune system is modulated by a number of molecules that dampen/inhibit 113 
the inflammatory response triggered by “activating” toll-like receptors and inflammasomes.   114 
Bacterial lipids and proteins derived from Gram negative and Gram positive bacteria (PAMPs) 115 
reaching the fetal membranes are potent activators of the innate immune response leading to 116 
inflammation. Numerous animal studies have shown that Gram negative bacterial 117 
lipopolysaccharide (LPS) precipitates preterm birth, and that the fetal membranes possess 118 
molecules that recognize bacterial products and trigger an inflammatory response, usually 119 
involving the activation of the transcription factor, NFkB (Courtois, 2005).  Endogenous 120 
enzymes (e.g., acyloxyacyl hydrolase, alkaline phosphatase) protect the host from the potent 121 
actions of LPS by altering LPS structure.    122 
A number of endogenous proteins with anti-microbial activity like lactoferrin, mannose-binding 123 
lectin 2, and fucosyltransferase 2 help protect exposed surfaces including mucosa, and the fetal 124 
membranes. The FUT2 (OMIM: ( +182100)  and MBL2 (OMIM: * 154545)
We analyzed WES data from neonatal DNA from 76 PPROM cases and 43 term controls 129 
born of African-American mothers to identify damaging mutations in innate immunity genes and 130 
discovered that there was an overrepresentation of these damaging alleles in PPROM cases. 131 
 genes are both 125 
expressed in the fetal membranes.  The defensin family of genes expressed maternally and by 126 
the fetus probably combat bacteria ascending from the vagina, but possibly from other sources. 127 
Several defensins are known to be produced by fetal membranes including (Avila, 2016). 128 
MATERIALS AND METHODS 132 
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Study Population: WES was performed on 76 PPROM cases and 43 healthy term control 133 
neonatal DNA samples all obtained in Richmond, Virginia.  Additional genotyping of select 134 
variants was performed on an independent cohort of 188 case and 175 control fetal/neonatal 135 
DNA samples collected in Richmond, Virginia and Detroit, Michigan. DNA was isolated from 136 
cord blood or umbilical cords.  Subjects were self-reported African-American women and their 137 
neonates receiving obstetrical care at MCV Hospitals, Richmond, VA (all samples in the initial 138 
WES) and Hutzel Hospital in Detroit, MI. The study was approved by the Institutional Review 139 
Boards of MCV Hospitals, Richmond, VA (IRB Number: HM15009); Wayne State University 140 
(IRB Numbers: 103897MP2F (5R), 082403MP2F (5R), 110605MP4F, 103108MP2F, 141 
052308MP2F) as well as NICHD (National Institute of Child Health and Human Development) 142 
(IRB Numbers: 0H97-CH-N065, OH98-CH-N001, OH97-CH-N067, OH99-CH-N056, OH09-CH-143 
N014). Subjects from Hutzel Hospital, Detroit, MI were enrolled under both Wayne State 144 
University as well as NICHD protocols and thus respective IRB numbers for both institutes are 145 
provided. Written informed consent was obtained from mothers before sample collection. 146 
Demographic and clinical data were obtained from surveys and medical records. Control DNA 147 
samples (n = 43 + 175) were obtained from neonates of singleton pregnancies delivered at term 148 
(> 37 weeks of gestation) of mothers with no prior history of PPROM or preterm labor. Cases of 149 
PPROM (n = 76 + 188) were defined as neonates from pregnancies complicated by 150 
spontaneous rupture of membranes prior to 37 weeks of gestation. The diagnosis of membrane 151 
rupture was based on pooling of amniotic fluid in the vagina, amniotic fluid ferning patterns and 152 
a positive nitrazine test. Women with multiple gestations, fetal anomalies, trauma, connective 153 
tissue diseases and medical complications of pregnancy requiring induction of labor were 154 
excluded.  A DNA biobank at Virginia Commonwealth University and Hutzel Hospital of PPROM 155 
cases and term controls collected using the same criteria as those used for for the WES cohort 156 
was employed for subsequent genotyping of selected mutations identified by WES (Modi et al., 157 
2017). 158 
Ancestry Estimates: Genetic ancestry was estimated to investigate population structure in the 159 
cases and control cohorts. Genetic ancestry estimates were generated in a two-way model of 160 
admixture, European and West African, for the neonates of each self-reported African-American 161 
study subject using 102 ancestry informative markers (AIMs) single nucleotide polymorphisms 162 
with large allele frequency differences between ancestral populations. (Modi et al., 2017). The 163 
mean allele frequency difference between ancestral populations for the AIMs panel was delta 164 
(δ)= 0.733. The AIMs panel was derived from the overlap of the WES and the Illumina African 165 
American Admixture Mapping Panel (Illumina, San Diego, CA) and genotyped using a custom 166 
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iPLEX assay (Agena Biosciences, San Diego, CA) for study subjects who were not part of the 167 
WES discovery set (Modi et al., 2017).  Prior allele frequencies derived from the HapMap West 168 
Africans (YRI, Yoruba in Ibadan, Nigeria) and Europeans (CEU, CEPH Utah residents with 169 
ancestry from northern and western Europe) were used to estimate individual genetic ancestry 170 
estimates following a maximum-likelihood approach.  171 
Whole Exome Sequencing Analysis: Whole exome capture and sequencing was performed at 172 
BGI (BGI, Cambridge, MA) using the SureSelect Target Enrichment System Capture Process 173 
followed by high-throughput sequencing on an Illimina HiSeq2000 platform with 50-100X 174 
coverage. The bioinformatics analysis for variant discovery and annotation was performed as 175 
described earlier (Modi et al., 2017). In brief, sequences were mapped to the human reference 176 
genome (build hg19) using BWA, followed by marking PCR duplicates using Picard tools  and 177 
base quality recalibration using GATK (Modi et al., 2017) GATK-HaplotypeCaller was used to 178 
identify variants in individual sample, followed by joint genotyping of all samples in the cohort for 179 
population-level analysis. The raw SNPs and INDELs were filtered for high quality and 180 
annotated for their functional effects using SnpEff tool and known variant databases like dbSNP, 181 
ClinVar and the 1000 Genomes Project. Damaging missense variants were selected on the 182 
basis of most deleterious predictions in both Polyphen2 (HumDiv - probably damaging) as well 183 
as SIFT (damaging) platforms.  PCR and Sanger sequencing was used to validate mutations 184 
detected by WES (Supplemental Table 1) or mutations were confirmed by custom genotyping. 185 
Custom Genotyping: The variants identified and selected for further analysis from Whole Exome 186 
Sequencing were validated and additional samples (an independent cohort of additional 188 187 
cases and 175 controls) were genotyped for the selected variants. Genotyping was performed 188 
on the Agena (previously Sequenom) MassArray iPLEX platform following manufacturer’s 189 
instructions at the University of Minnesota Genomics Center (Modi et al., 2017).  The primer 190 
sets used for iPlex genotyping are presented in Supplemental Table 2.  191 
Statistical analysis:  Mean levels of demographic variables were tested using a 2-tailed 192 
Student’s t-test. Count data (for gravidity and parity) was square root transformed before 193 
performing tests. P-values < 0.05 were considered statistically significant. The paired Wilcoxon 194 
rank-sum test were used to assess significant differences in minor allele frequencies. 195 
 196 
RESULTS 197 
WES was performed on 76 PPROM and 43 healthy term control neonatal DNA samples.  198 
The demographic characteristics of the WES study population is presented in Table 1. The 199 
characteristics of the follow-up cohort have been previously reported (Modi et al., 2017).  With 200 
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152 chromosomes, the probability of detecting a variant with an allele frequency of 0.005 was 201 
78%. 202 
 The WES PPROM cases and term controls had similar West African and European 203 
ancestry based on genotyping of 102 ancestry informative markers (Means + S.D.; West African 204 
ancestry: PPROM cases: 0.695 + 0.073 (mean + S.D.); Term controls 0.698 + 0.087 (p>0.10)).  205 
A total of 35 candidate genes were selected for investigation of nonsense mutations and 206 
insertions/deletions causing damaging frameshift mutations (Table 2) based on their 207 
involvement in the innate immune response and host defense against microbes.  Mutations 208 
identified through WES were validated by direct sequence analysis or specific genotyping 209 
assays. The mutations were evaluated in an independent cohort of an additional 188 PPROM 210 
cases and 175 controls.  211 
Mutations in genes negatively regulating innate immunity:  We detected mutations in the 212 
CARD6, CARD8, NLRP10, NLRP12, NOD2, and TLR10 genes (Table 3).  Several of these 213 
were only found in PPROM cases (CARD6, NLRP10, and NOD2) in both WES and the follow-214 
up genotyping cohorts.  The SNP for the CARD6 nonsense mutation has two alternative alleles 215 
C or G.  We confirmed by DNA sequence analysis that the PPROM case had the G allele 216 
creating the stop codon TAG, which truncates the 1037 amino acid protein at position 560, 217 
which retains the caspase activation and recruitment (CARD) domain, but deletes the IMPDH 218 
(inosine 5'-monophosphate dehydrogenase/GMP reductase) domain and C-terminal proline-rich 219 
domain.  This nonsense mutation was detected in 2 PPROM cases (combined WES and follow-220 
up genotyping) and none of the combined term pregnancy controls. The one heterozygous 221 
NLRP10 nonsense mutation detected only in a PPROM case truncates the 655 amino acid 222 
protein at position 103.  The NOD2 frameshift mutation truncates the C-terminal 33 amino acids 223 
from the 1040 amino acid protein, disrupting a leucine-rich repeat. Mutations in CARD8, 224 
NLRP12 and TLR10 were found in both PPROM cases and controls. 225 
Mutations in LPS detoxifying enzymes: A nonsense mutation was found in AOAH, which 226 
encodes an enzyme that catalyzes the hydrolysis of acyloxylacyl-linked fatty acyl chains from 227 
LPS.  The nonsense mutation disrupts the 688 amino acid protein at position 556, retaining the 228 
lipase consensus sequence.  This mutation was found in both PPROM cases and term controls. 229 
Mutations in anti-microbial protein genes: A heterozygous nonsense mutation was found in  230 
DEFB1, which encodes beta-defensin 1, an anti-microbial factor that is produced by amnion 231 
epithelial cells. The rs5743490 SNP reference allele is C with two reported alternatives: T, which 232 
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results in a synonymous codon change that is functionally not significant,  and A which creates 233 
a stop codon (TGA).  We sequence verified that the allele in our PPROM cases was an A.  This 234 
stop codon truncates the mature beta defensin 1 peptide sequence after 4 amino acids, so no 235 
active peptide made (Porto et al., 2016).  Additionally, the translated truncated N-terminal 236 
peptide could serve as a dominant negative, competing for the intact signal peptide or 237 
processing protease of intact beta-defensin 1 peptide encoded by the other DEFB1 allele.  The 238 
heterozygous DEFB1 mutation was found in 6 PPROM cases (WES and follow-up genotyping 239 
combined) and no term controls.  240 
A heterozygous nonsense mutation in MBL2 was identified which deletes the 38 terminal 241 
amino acids in the C-type lectin carbohydrate recognition domain of the 248 amino acid protein.  242 
The reference allele of this SNP is a G, with alternate alleles of C, producing a benign missense 243 
variant or a T, creates a TAG stop codon. We confirmed by DNA sequence analysis that the 244 
minor allele in our PPROM cases was a T.  This nonsense mutation was detected in 6 of the 245 
total PPROM  cases  and none of the total term controls.  Using RT-PCR, we demonstrated that 246 
the MBL2 gene is expressed in fetal membranes (Supplemental data Figure 1).  247 
Three mutations were discovered in the FUT2 gene, which encodes a fucosyltransferase 248 
involved in protecting epithelium from bacterial infection.  One of the nonsense mutations 249 
(rs143482452) was found in one PPROM case (combined WES and follow-up genotyping 250 
cohort) only and not in the combined term controls.   Another one (rs601338) has a relatively 251 
high minor allele frequency and was detected in PPROM cases and term controls.  The FUT2 252 
gene is expressed in amnion epithelial cells, and mutations that disrupt the protein cause the 253 
“non-secretor” phenotype, which is associated with absent ABH blood groups (Goto et al., 254 
2016). 255 
All of the mutations described above were heterozygous, except for FUT2 rs601338.  In 256 
the case of this common mutation, there were 16 homozygous PPROM cases (21%) out of the 257 
76 cases, and 4 homozygous controls (9.3%) out of the 43 term pregnancies.  Among this 258 
cohort, 7 subjects had di-genic mutations, two with TLR10 rs62617795 mutation and the 259 
CARD8 mutation; 2 with AOAH mutations, one with a TLR10 rs62617795 mutation, and one 260 
with the CARD8 mutation; and 3 with the FUT2 rs601338 mutation in combination with either 261 
the CARD6 mutation, MBL2 mutation, and NLRP12 nonsense mutation. 262 
We found no nonsense or damaging frameshift mutations in ALPP, BPI, CAMP, DEFA1, 263 
DEFB4A, DEFB103A, IL10, IL10RA, IL10RB, LBP, LTF, LYZ, NLRP3, SOCS1, SOCS2, 264 
SOCS3, SOCS4, SOCS5, SOCS6, NFKBIA, NFKBIB, NFKBID, NFKBIE, NFKBIZ and NOD1 265 
Therefore, these genes did not undergo further interrogation.   266 
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Of the 14 mutations identified through WES, 10 had minor allele frequencies in the 267 
combined WES and follow-up genotyping cohort that were nominally greater in PPROM cases 268 
than term controls.  The allele frequency of two mutant alleles were similar in cases and 269 
controls, and two mutations were more frequent in controls than PPROM cases.  A paired 270 
Wilcoxon rank sum test estimated that across loci, variants were overrepresented at PPROM 271 
case loci were compared to term controls (Empirical P-value from 10K permutations = 0.0416). 272 
  In addition to nonsense and damaging frameshift mutations, a number of rare predicted 273 
damaging or known pathogenic missense mutations (e.g., NOD2 rs34936594) were identified 274 
through WES in the candidate genes (Supplemental Table 3).  The allele frequencies of these 275 
missense mutations were higher in the 76 PPROM cases than the 43 term controls.  The 276 
association of these predicted rare missense variants with PPROM needs to be replicated with 277 
a larger sample size.  278 
DISCUSSION 279 
Our working hypothesis of whether neonatal genes that negatively regulate innate 280 
immunity or help the host combat microbes and their noxious products would be more likely to 281 
harbor rare, damaging mutations in PPROM cases was supported by our findings.  Interestingly, 282 
there were a number of important negative regulators of innate immunity and the host defense 283 
system that were not mutated (e.g., IL10, IL10RA, IL10RB NLRP3, SOCS1, SOCS2, SOCS3, 284 
SOCS4, SOCS5, SOCS6, NFKBIA, NFKBIB, NFKBID, NFKBIE, NFKBIZ, and NOD1).  Of 285 
course, the limited WES sample size may have precluded the detection of very rare alleles in 286 
these genes. 287 
Inflammasomes and toll-like receptors are critical to host defense mechanisms during 288 
the physiological and pathological inflammatory processes in the chorioamniotic membranes 289 
that accompany labor. Thus, it is not unexpected that mutations in genes that negatively 290 
regulate the inflammasome as well as the toll-like receptors were detected in PPROM cases 291 
(Gotsch et al., 2008; Eisenbarth et al., 2012; Oosting et al., 2014). 292 
Mutations in genes encoding host defense mechanisms against microbes had been 293 
anticipated based on studies documenting differential expression of the proteins in fetal 294 
membranes associated with labor with ruptured and non-ruptured membranes (Erez et al., 295 
2009)  Notable in this regard are the rare heterozygous damaging mutations in DEFB1, FUT2 296 
and MBL2 that were found only in PPROM cases.  Variation in these genes have been 297 
previously associated with increased risk of infection and in some cases preterm birth (Annells 298 
et al., 2005; Gibson et al., 2011; Jaffe et al., 2013).    299 
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The discovery of a rare nonsense mutation in the DEFB1 gene is of interest in that 300 
variation in this gene (rs1047031, a SNP in the 3’-UTR) has been associated with chronic and 301 
aggressive periodontitis, a condition associated with preterm birth (Schaefer et al., 2010).  302 
However, the functional significance of the rs1047031 minor allele has not been established.  303 
Polymorphisms in the MBL2 gene are more frequent in African-Americans and multiple 304 
studies have suggested an association between MBL2 genetic variants that result in dimished 305 
MBL2 protein levels and preterm birth, and conditions commonly found in preterm pregnancies 306 
including chorioamnionitis (Annells et al., 2004; Annells et al., 2005; Capece et al., 2014; 307 
Gibson et al., 2011; Jaffe et al., 2013; Nedovic et al., 2014).   Our discovery of a nonsense 308 
mutations that significantly truncates the MBL2 protein is thus consistent with the notion that 309 
loss of this anti-microbial protein increases risk of prematurity. 310 
Given the distribution of allele frequencies of FUT2 mutations we identified, we 311 
speculate that the “non-secretor” type is not a strong risk factor for PPROM since the more 312 
common mutation was found at allele frequencies that were similar in PPROM cases and 313 
controls.  It is possible, however, that if both mother and fetus harbor mutations in FUT2 that 314 
there could be an increased risk of PPROM, a possibility that we did not explore. 315 
It is noteworthy that genes associated with inflammatory bowel disease also appear to 316 
have an association with PPROM, including CARD and NLRP genes, NOD2 and BRIC2 (Hugot 317 
et al., 2001; Andreoletti et al., 2017).  Although not included in the 35 candidate genes, a novel 318 
heterozygous nonsense mutation in BIRC2 (NC_000011.10: g.102248476T>G), creating a stop 319 
codon at position 539 in this 618 amino acid protein, which deletes the C-terminal zinc finger 320 
domain), a gene that negatively regulates the NOD1/NOD2 signaling pathway, and has been 321 
recently found to be associated with pediatric inflammatory bowel disease, was discovered in 322 
the WES of one PPROM case and no term controls (Andreoletti et al., 2017).  A heterozygous 323 
damaging frameshift mutation (rs779381525, NC_000010.10 g.49440248_49440249insA) was 324 
detected in FRMPD2, another gene associated with the NOD2 pathway, in one WES PPROM 325 
case.  326 
Chorioamnionitis is often found in PPROM fetal membrane specimens, and the 327 
pathways that lead to an accentuated bowel inflammation in Crohn’s disease and ulcerative 328 
colitis may also contribute to the severity of chorioamnionitis and therefore risk of PPROM.  329 
Preterm birth is associated with maternal inflammatory bowel disease but there are no reports 330 
that we are aware of that link inflammatory disease in offspring to increased risk of preterm birth 331 
and PPROM (Broms et al., 2016; Caruso et al., 2014; Getahun et al., 2014; Palomba et al., 332 
2014; Shand et al., 2016).  333 
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We previously examined the association between 2936insC (rs2066847) in the 334 
CARD15/NOD2 gene and PPROM in African-Americans and reported that this frameshift 335 
mutation was only found in term controls (Ferrand et al., 2002). This study used genotyping by 336 
restriction length polymorphism (RFLP) with digestion with Nla IV which cuts the sequence: 337 
GGNNCC.  We re-evaluated the putative mutations in the control samples previously analyzed 338 
using DNA sequencing and discovered that none of them harbored the frameshift mutation, 339 
indicating that the RFLP genotyping was flawed. The genotyping methods employed in the 340 
present study can distinguish these frameshift mutations, and therefore provides evidence that 341 
2936insC is a risk allele for PPROM. 342 
The mutations that we identified could be spontaneous, or inherited from the father or 343 
mother (Li et al., 2017).  We speculate that maternal inheritance may be most likely in the 344 
setting of PPROM, since an enhanced maternal reproductive tract inflammatory response to 345 
bacteria or viruses, or deficiency in endogenous anti-microbial defenses would presumably act 346 
in synergy with similar defects in the fetus when both mother and fetus are heterozygous for 347 
damaging mutations  (Plunkett et al., 2009). 348 
In conclusion, our WES studies, supplemented with additional target genotyping, 349 
revealed a number of rare damaging mutations, the majority being heterozygous, that are more 350 
frequent in neonates born of pregnancies complicated by PPROM.  These findings suggest that 351 
the increased risk of preterm birth in African-Americans may be conferred by mutations and 352 
damaging missense variants in genes encoding proteins involved in dampening the innate 353 
immune response and protecting the host against microbial infection. 354 
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Table 1: Study subject characteristics for WES 
 
PPROM cases, N=76; Term controls, N=43 
Characteristic Cases Mean (SD) 
 
Controls Mean (SD) 
 
 
p-value 
 
 
Maternal Age (years) 
 
27.18 (5.33) 26.02 (5.32) 
 
0.256 
Gestational Age at Delivery (weeks) 30.05 (4.17) 38.93 (1.16) <0.001 
Neonatal Weight (kgs) 1.69 (1.59) 3.14 (0.46) <0.001 
Gravidity 3.53 (2.04) 3.25 (2.57) 0.555 
Parity 1.47 (1.57) 1.35 (1.41) 0.657 
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Table 2. Candidate genes selected for analysis 
 
                              Category Gene IDs and (OMIM number)  
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Innate immune response modulators 
CARD6  (* 609986), CARD8 (* 609051)  
 
IL10 ( * 124092), IL10RA (* 146933)  
 
IL10RB  (* 123889), NFKBIA (* 164008) 
 
NFKBIB ( * 604495), NFKBID,  
 
 NFKBIE ( * 604548), NFKBIZ (* 608004)  
 
   
NLRP3 ( * 606416), NLRP10 (* 609662) 
  
NLRP12 ( * 609648), NOD1(* 605980)  
  
NOD2 (* 605956), TLR10 (* 606270)  
  
 SOCS1( * 603597), SOCS2 (* 605117)  
  
 SOCS3 ( * 604176), SOCS4  (* 616337)  
 
 SOCS5 ( * 607094), SOCS6 (* 605118)  
  
  
                          LPS detoxification 
 
ALPP ( * 171800), AOAH (* 102593)  
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 Table 3. Damaging mutations identified in genes involved in modulation of the innate immune response in PPROM cases. 
 
Mutations identified through WES (76 PPROM, 43 term controls) were validated by direct sequence analysis or genotyping using 
TaqMan reagents.  The mutations were evaluated in an independent cohort of an additional 188 PPROM cases and 175 controls. 
Genotyping was performed on the Agena MassArray iPLEX platform. All allele frequencies were based on called genotypes 
excluding missing samples or those samples without a genotype call.  MAF=minor allele frequency.  
Gene ID Chromosome Position   SNP ID Ref- 
Allele 
Alternate- 
Allele 
Effect               Minor Allele AA 
Position  
(residue 
change) 
Minor Allele  
Frequency 
Cases/Controls 
Sequence Variant 
AOAH   7p14.2 36514524 rs145455591 C T Nonsense                T    556 0.036/0.026 NC_000007.14:g.36514524C>T  
CARD6   5p13.1 40853011 rs150487186 T G Nonsense                G    560 0.004/0.000 NC_000005.10:g.40853011T>G 
CARD8 19q13.33 48231760 rs140826611 - AA Frameshift               AA    148 0.016/0.006 NC_000019.10:g.48231760_48231761insAA  
DEFB1   8p23.1 6870777 rs5743490 C A Nonsense                A       37 0.011/0.000 NC_000008.11:g.6870777C>A  
FUT2 19q13.3 48703417 rs601338 G A Nonsense                A    154 0.374/0.376 NC_000019.10:g.48703417G>A 
FUT2 19q13.3 48703041 rs143482452 C T Nonsense                T      29 0.002/0.000 NC_000019.10:g.48703041C>T 
FUT2 19q13.3 48703767 rs1799761 C - Frameshift               C      271 0.007/0.012 NC_000019.10:g.48703767delC 
MBL2 10q21.1 52768256 rs74754826 G T Nonsense                T     210 0.011/0.000 NC_000010.11:g.52768256G>T  
NLRP10 11p15.4 7961305 
 
rs765522475 C T Nonsense                T    103 0.002/0.000 NC_000011.10:g.7961305C>T 
NLRP12 19q13.42 53795911 rs35064500 C T Nonsense                T  1017 0.021/0.007 NC_000019.10:g.53795911C>T   
NLRP12 19q13.42 53795917 rs776426826     
                     
AG - Frameshift                -  1015 0.002/0.003 NC_000019.10:g.53795917_53795918delAG   
NOD2 16q12.1 50729867 rs2066847 - C Frameshift               C  1007 0.004/0.000 NC_000016.10:g.50729867_50729868insC 
TLR10   4p14 38774483 rs62617795 C T Nonsense                T   370 0.020/0.016 NC_000004.12:g.38774483C>T  
TLR10   4p14 38775590 rs140873456 A G Start loss                 G       1 0.003/0.003 NC_000004.12:g.38775590A>G  
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